Login / Signup

The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.

Anna K AnderssonJing MaJianmin WangXiang ChenAmanda Larson GedmanJinjun DangJoy NakitandweLinda HolmfeldtMatthew ParkerJohn EastonRobert HuetherRichard KriwackiMichael RuschGang WuYongjin LiHeather MulderSusana RaimondiStanley B PoundsGuolian KangLei ShiJared BecksfortPankaj GuptaDebbie Payne-TurnerBhavin VadodariaKristy BoggsDonald YergeauJayanthi ManneGuangchun SongMichael EdmonsonPanduka NagahawatteLei WeiCheng ChengDeqing PeiRosemary SuttonNicola C VennAlbert ChetcutiAmanda RushDaniel CatchpooleJesper HeldrupThoas FioretosCharles LuLi DingChing-Hon PuiSheila ShurtleffCharles G MullighanElaine R MardisRichard K WilsonTanja A GruberJinghui ZhangJames R Downingnull null
Published in: Nature genetics (2015)
Infant acute lymphoblastic leukemia (ALL) with MLL rearrangements (MLL-R) represents a distinct leukemia with a poor prognosis. To define its mutational landscape, we performed whole-genome, exome, RNA and targeted DNA sequencing on 65 infants (47 MLL-R and 18 non-MLL-R cases) and 20 older children (MLL-R cases) with leukemia. Our data show that infant MLL-R ALL has one of the lowest frequencies of somatic mutations of any sequenced cancer, with the predominant leukemic clone carrying a mean of 1.3 non-silent mutations. Despite this paucity of mutations, we detected activating mutations in kinase-PI3K-RAS signaling pathway components in 47% of cases. Surprisingly, these mutations were often subclonal and were frequently lost at relapse. In contrast to infant cases, MLL-R leukemia in older children had more somatic mutations (mean of 6.5 mutations/case versus 1.3 mutations/case, P = 7.15 × 10(-5)) and had frequent mutations (45%) in epigenetic regulators, a category of genes that, with the exception of MLL, was rarely mutated in infant MLL-R ALL.
Keyphrases